White David 4
4 · FIVE PRIME THERAPEUTICS, INC. · Filed Feb 26, 2020
Insider Transaction Report
Form 4
White David
See Remarks
Transactions
- Award
Common Stock
2020-01-20+20,000→ 35,000 total - Award
Common Stock
2020-02-24+10,000→ 45,000 total - Award
Employee Stock Option (right to buy)
2020-02-24+25,000→ 25,000 totalExercise: $5.25Exp: 2030-02-23→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]Represents shares of restricted stock, which will vest in its entirety on September 30, 2020, provided the reporting person provides services to Five Prime Therapeutics, Inc. (the "Company") through such date.
- [F2]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of February 24, 2021, 2022 and 2023, provided the reporting person provides services to the Company through each such date.
- [F3]The shares underlying this option vest at a rate of one forty-eighth (1/48) per month following February 24, 2020, provided the reporting person provides services to the Company through each such date.